GF
LGND icon

Gabelli Funds’s Ligand Pharmaceuticals LGND Stock Holding History

Gabelli Funds’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-44,083
Closed -$2.73M – 1337
2020
Q4 		$2.73M Sell
44,083
-8,015
-15% -$457K 0.02% 628
2020
Q3 		$3.1M Buy
52,098
+17,633
+51% +$1.2M 0.02% 559
2020
Q2 		$2.4M Sell
34,465
-42,162
-55% -$2.67M 0.02% 614
2020
Q1 		$3.48M Sell
76,627
-16,030
-17% -$909K 0.03% 497
2019
Q4 		$6.03M Hold
92,657
– – 0.04% 464
2019
Q3 		$5.75M Buy
92,657
+802
+0.9% +$50.4K 0.04% 470
2019
Q2 		$6.54M Hold
91,855
– – 0.04% 449
2019
Q1 		$7.2M Buy
91,855
+26,933
+41% +$2.04M 0.05% 429
2018
Q4 		$5.5M Buy
64,922
+37,671
+138% +$4.02M 0.04% 480
2018
Q3 		$4.67M Hold
27,251
– – 0.03% 590
2018
Q2 		$3.52M Sell
27,251
-16,952
-38% -$1.89M 0.02% 654
2018
Q1 		$4.55M Sell
44,203
-7,213
-14% -$713K 0.03% 577
2017
Q4 		$4.39M Sell
51,416
-2,405
-4% -$208K 0.03% 596
2017
Q3 		$4.57M Sell
53,821
-8,015
-13% -$635K 0.03% 588
2017
Q2 		$4.68M Sell
61,836
-8,015
-11% -$561K 0.03% 575
2017
Q1 		$4.61M Buy
69,851
+36,188
+108% +$2.38M 0.03% 582
2016
Q4 		$2.13M Buy
+33,663
New +$2.12M 0.01% 768

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Gabelli Funds's LGND Position: Q1 2021 in Review

Gabelli Funds sold out of Ligand Pharmaceuticals (LGND) in Q1 2021, closing a stake of 44,083 shares — an estimated $2.73M sold.

Gabelli Funds first reported a position in LGND in Q4 2016 and held it in 17 quarters. The position peaked at $7.2M in Q1 2019. 228 funds tracked by Wall St. Rank hold LGND as of Q1 2021.

  • Gabelli Funds reported no remaining Ligand Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Gabelli Funds sold 44,083 Ligand Pharmaceuticals shares in Q1 2021, an estimated $2.73M.
  • Gabelli Funds first reported a position in Ligand Pharmaceuticals in Q4 2016 and held it in 17 quarters.
  • Gabelli Funds's Ligand Pharmaceuticals position peaked at $7.2M in Q1 2019.
  • 228 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2021.

Based on Gabelli Funds's 13F filing for Q1 2021, filed 14 May 2021.